argenx SE
Efgartigimod
CIDP
Resolved
58days ago
FDA decision · May 10, 2026
What's at stake
The FDA's approval decision on Efgartigimod for CIDP is due May 10, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 6-K
verified 13h ago
“PDUFA May 10, 2026 Submission on Track “”